SCHEMBL9931209

SCHEMBL9931209

FC(F)(F)C(F)(F)CCCCCCC1CCCN1

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.34
CXCR4 P61073 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2636384 1.00 HRH3 (0.34) HRH3CXCR4
SCHEMBL2636046 1.00 HRH3 (0.34) HRH3CXCR4
SCHEMBL9931712 1.00 HRH3 (0.34) HRH3CXCR4
SCHEMBL16538809 0.84 KMT2A (0.35)
SCHEMBL16538617 0.82 KMT2A (0.35) HRH3
SCHEMBL16538419 0.82 KMT2A (0.35) HRH3
SCHEMBL16538738 0.79 KMT2A (0.38)
SCHEMBL16538541 0.79 KMT2A (0.35) HRH3
SCHEMBL16538558 0.79 KMT2A (0.35) HRH3
SCHEMBL16538462 0.79 KMT2A (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157421-A1 17Beta-Alkyl-17Alpha-oxy-estratrienes BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157421-A1 17Beta-Alkyl-17Alpha-oxy-estratrienes CYP19A1, HSD17B11, CYP17A1 HRH3 3889/4885CXCR4 3019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.